Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials.
J Rheumatol
; 49(6): 566-576, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-35232809
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Rheumatology
/
Antirheumatic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
J Rheumatol
Year:
2022
Document type:
Article
Affiliation country: